ORIGINAL RESEARCH article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1589843

This article is part of the Research TopicMicrobiota-Immunity Dynamics in Cancer: Mechanisms and Implications for Treatment StrategiesView all 4 articles

Lung Microbiome Alterations Correlate with Immune Imbalance in Non-Small Cell Lung Cancer

Provisionally accepted
  • First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

The final, formatted version of the article will be published soon.

Background: Current understanding of the link between microbiota imbalance and immune function in non-small cell lung cancer (NSCLC) has not been fully elucidated.This study aims to explore the link between dysbiotic lung microbiota and immunity in NSCLC, which may provide valuable information for disease progression monitoring and prognosis prediction.Methods: Lung microbial communities from both the tumor-affected (n = 43) and contralateral healthy sides (n = 38) of lung cancer patients were analyzed by 16S rRNA sequencing. The association between microbial abundance and tumor stages, metastasis or not, nodule size, PD-L1 expression, as well as Ki-67 levels was conducted. Mann-Whitney tests were used to evaluate differences in the systemic immune-inflammation index (SII), T cell subsets (CD3 + , CD4 + , CD8 + ), as well as the CD4 + /CD8 + ratio between different microbial expression patterns of Prevotella and Veillonella.Results: Significant β-diversity differences were observed between the tumor-bearing and contralateral normal lungs in individuals diagnosed with lung carcinoma. A notable increase in Prevotella (P = 0.044) and Veillonella (P = 0.02) was detected within NSCLC-affected lungs, whereas Pseudomonas (P = 0.008) as well as Staphylococcus (P = 0.033) were significantly reduced. Increased levels of Veillonella were detected in NSCLC patients at stage IIIB-IV and were positively correlated with Ki-67 expression. Furthermore, patients with higher abundance of Prevotella and Veillonella exhibited a significantly elevated systemic immune-inflammation index (SII) compared to the lower-abundance group (P = 0.0329), while their CD8 + T cell levels were significantly decreased in the higher abundance group (P = 0.0027).Microbial composition differed significantly between the tumor-affected and healthy sides in lung cancer patients. Veillonella was more abundant NSCLC patients at stage IIIB-IV, while increased Prevotella and Veillonella abundance correlated positively with SII but negatively with CD8 + T cell levels. These findings provide valuable insights into tumor-associated microbiota for monitoring disease advancement, treatment stratification and prognostic assessment.

Keywords: Non-small cell lung cancer, Lung microbiota, Prevotella, Veillonella, systemic immune-inflammation index, CD8 + T cell

Received: 08 Mar 2025; Accepted: 24 Apr 2025.

Copyright: © 2025 Cheng and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Huaqi Wang, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.